Suspected Cushings syndrome, with elevated cortisol levels consistent with a diagnosis
Current evidence does not establish guaranteed beta-cell protection or an approved therapeutic use
However, semaglutide's appetite-suppressing effects are powerful, and some users find they lose more than their initial target once treatment begins
Compared with participants who received placebo injections, those treated with semaglutide showed: Slower biological aging across multiple epigenetic clocks tied to inflammation and the health of the blood, brain, heart, kidneys, liver, and metabolism
This matters when considering dose-response relationships: a heavier subject at 8 mg may lose more kilograms than a lighter subject at 12 mg, even though the relative loss looks different on paper